Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Sleep and Breathing
Published in: Sleep and Breathing 4/2012

01-12-2012 | Original Article

Longitudinal analyses of polysomnographic variables, serum androgens, and parameters of glucose metabolism in obese adolescents with polycystic ovarian syndrome

Authors: Gideon de Sousa, Bernhard Schlüter, Thomas Menke, Eckardt Trowitzsch, Werner Andler, Thomas Reinehr

Published in: Sleep and Breathing | Issue 4/2012

Login to get access

Abstract

Purpose

The prevalence of obstructive sleep apnea syndrome (OSAS) is clearly increased in adults with polycystic ovarian syndrome (PCOS), whereas OSAS does not seem to be frequent in adolescents with PCOS, pointing towards the fact that some patients with PCOS develop OSAS in the further course of the disease. We therefore aimed to analyze the changes of polysomnographic variables in obese adolescents with PCOS in a longitudinal analysis.

Methods

Fifteen adolescents with PCOS (age 15.3 years ± 1.2, BMI 32.9 kg/m2 ± 6.4, SDS-BMI 2.5 ± 0.8) underwent overnight 12-channel polysomnography at baseline and after a mean duration of 28 ± 6 months (age 17.8 years ± 1.1, BMI 32.7 kg/m2 ± 7.0, SDS-BMI 2.1 ± 0.9). After performing the initial polysomnography, we treated hyperandrogenemia and insulin resistance in the study group. We determined parameters of body weight/body composition, parameters of glucose metabolism, and serum androgens in all patients at baseline and follow-up. At follow-up, we compared the polysomnographic variables of the study group to those of healthy female adults.

Results

The polysomnographic variables, the parameters of body weight/body composition, and the parameters of glucose metabolism in the study group did not change significantly during the observation period. The serum levels of total testosterone and sex hormone binding globulin increased significantly, whereas free androgen index decreased significantly. At follow-up, the polysomnographic variables of the study group did not differ from those of healthy female adults.

Conclusions

OSAS does not seem to develop in adolescents with PCOS being treated for hyperandrogenism and insulin resistance. The pathogenesis of OSAS in PCOS needs to be examined in larger controlled studies.
Literature
1.
Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078–3082CrossRefPubMed
2.
Zawadski JK, Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR (eds) Polycystic ovary syndrome. Blackwell Scientific Publications, Boston, pp 377–384
3.
Sam S, Dunaif A (2003) Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab 14:365–370CrossRefPubMed
4.
5.
Fogel RB, Malhotra A, Pillar G, Pittman SD, Dunaif A, White DP (2001) Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 86:1175–1180CrossRefPubMed
6.
Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP (2001) Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 86:517–520CrossRefPubMed
7.
Gopal M, Duntley S, Uhles M, Attarian H (2002) The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med 3:401–404CrossRefPubMed
8.
Tasali E, Van Cauter E, Hoffman L, Ehrmann DA (2008) Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome. J Clin Endocrinol Metab 93:3878–3884CrossRefPubMed
9.
Tasali E, Van Cauter E, Ehrmann DA (2006) Relationship between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab 91:36–42CrossRefPubMed
10.
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353:2034–2041CrossRefPubMed
11.
Martinez D, Klein C, Rahmeier L, da Silva RP, Fiori CZ, Cassol CM, Gonçalves SC, Bos AJ (2011) Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors. Sleep Breath Jul 28. PMID: 21796489/DOI: 10.​1007/​s11325-011-0559-0 [Epub ahead of print]
12.
Yang SQ, Han LL, Dong XL, Wang CY, Xia H, Liu P, Wang JH, He PP, Liu SN, Li MX (2011) Mal-effects of obstructive sleep apnea on the heart. Sleep Breath Sep 18. PMID: 21928076/DOI: 10.​1007/​s11325-011-0566-1 [Epub ahead of print]
13.
de Sousa G, Schlüter B, Buschatz D, Menke T, Trowitzsch E, Andler W, Reinehr T (2010) A comparison of polysomnographic variables between obese adolescents with polycystic ovarian syndrome and healthy, normal-weight and obese adolescents. Sleep Breath 14:33–38CrossRefPubMed
14.
de Sousa G, Schlüter B, Menke T, Trowitzsch E, Andler W, Reinehr T (2010) A comparison of polysomnographic variables between adolescents with polycystic ovarian syndrome and healthy controls. IJCM 1:48–53CrossRef
15.
de Sousa G, Schlüter B, Buschatz D, Menke T, Trowitzsch E, Andler W, Reinehr T (2011) The impact of insulin resistance and hyperandrogenemia on polysomnographic variables in obese adolescents with polycystic ovarian syndrome. Sleep Breath Jan 8. PMID: 21221823/DOI: 10.​1007/​s11325-010-0469-6 [Epub ahead of print]
16.
de Sousa G, Schlüter B, Menke T, Trowitzsch E, Andler W, Reinehr T (2011) Relationships between polysomnographic variables, parameters of glucose metabolism, and serum androgens in obese adolescents with polycystic ovarian syndrome. J Sleep Res 20:472–478CrossRefPubMed
17.
Subramanian S, Jayaraman G, Majid H, Aguilar R, Surani S (2011) Influence of gender and anthropometric measures on severity of obstructive sleep apnea. Sleep Breath Oct 28. PMID: 22033627/DOI: 10.​1007/​s11325-011-0607-9 [Epub ahead of print]
18.
Reinehr T, Temmesfeld M, Kersting M, de Sousa G, Toschke AM (2007) Four year follow-up of children and adolescents participating in an obesity intervention program. Int J Obes 31:1074–1077CrossRef
19.
Reinehr T, de Sousa G, Toschke M, Andler W (2006) Long-term follow-up of cardiovascular risk factors in obese children after intervention. Am J Clin Nutr 84:490–496PubMed
20.
Cole TJ, Belizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240–1243CrossRefPubMed
21.
Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß C, Hesse V, von Hippe A, Jaeger U, Johnsen D, Korte W, Menner K, Müller G, Müller JM, Niemann-Pilatus A, Remer T, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Zieglerund A, Hebebrand J (2001) Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd 149:807–818CrossRef
22.
Cole TJ (1990) The LMS method for constructing normalized growth standards. Eur J Clin Nutr 44:45–60PubMed
23.
Slaughter MH, Lohman TG, Boileau RA, Horswill CA, Stillman RJ, Van Loan MD, Bemben DA (1988) Skinfold equations for estimation of body fatness in children and youth. Hum Biol 60:709–723PubMed
24.
Kromeyer-Hausschild K, Gläßer N, Zellner K (2008) Waist circumference percentile in Jena children (Germany) 6 to 18 years of age. Aktuel Ernaehr Med 33:116–122CrossRef
25.
Reinehr T, de Sousa G, Roth CL, Andler W (2005) Androgens before and after weight loss in obese children. J Clin Endocrinol Metab 90:5588–5595CrossRefPubMed
26.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
27.
Association AD (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 5:10
28.
Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. U.S. Government Printing Office, Washington DC
29.
AASM (1992) EEG arousals: scoring rules and examples. A preliminary report from the sleep disorders atlas task force of the American Sleep Disorders Association. Sleep 15:174–184
30.
AASM (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22:667–689
31.
Subramanian S, Desai A, Joshipura M, Surani S (2007) Practice patterns of screening for sleep apnea in physicians treating PCOS patients. Sleep Breath 11:233–237CrossRefPubMed
32.
Kalra M, Inge T, Garcia V, Daniels S, Lawson L, Curti R, Cohen A, Amin R (2005) Obstructive sleep apnea in extremely overweight adolescents undergoing bariatric surgery. Obes Res 13:1175–1179CrossRefPubMed
33.
Redline S, Tishler PV, Schluchter M, Aylor J, Clark K, Graham G (1999) Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med 159:1527–1532PubMed
34.
Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, Porte D Jr (2001) Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr 131:354S–360SPubMed
35.
36.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:143–3421CrossRef
37.
Buchner NJ, Quack I, Stegbauer J, Woznowski M, Kaufmann A, Rump LC (2011) Treatment of obstructive sleep apnea reduces arterial stiffness. Sleep Breath Jan 7. PMID: 21213062/DOI: 10.​1007/​s11325-010-0465-x [Epub ahead of print]
Metadata
Title
Longitudinal analyses of polysomnographic variables, serum androgens, and parameters of glucose metabolism in obese adolescents with polycystic ovarian syndrome
Authors
Gideon de Sousa
Bernhard Schlüter
Thomas Menke
Eckardt Trowitzsch
Werner Andler
Thomas Reinehr
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Sleep and Breathing / Issue 4/2012
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-011-0620-z

Other articles of this Issue 4/2012

Sleep and Breathing 4/2012 Go to the issue

Editorial (invited)

Prediction formulas for nasal continuous positive airway pressure in patients with obstructive sleep apnea syndrome

Original Article

Elevated incidence of sleep apnoea in acromegaly—correlation to disease activity

Original Article

Polysomnography in stable COPD under non-invasive ventilation to reduce patient–ventilator asynchrony and morning breathlessness

Original Article

Three-dimensional reconstruction of soft palate modeling from subject-specific magnetic resonance imaging data

Original Article

Cromoglycate, reproterol, or both—what’s best for exercise-induced asthma?

Case Report

Late-onset, insidious course and invasive treatment of congenital central hypoventilation syndrome in a case with the Phox2B mutation: case report
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits